Vector saliva in vaccines for visceral leishmaniasis: A brief encounter of high consequence?
Visceral leishmaniasis (VL) is a vector-borne disease transmitted by phlebotomine sand flies and remains the most serious form of the disease with no available human vaccine. Repeatedly, studies have demonstrated the immunogenicity and protective efficacy of a number of sand fly salivary proteins ag...
Saved in:
Main Authors: | Shaden eKamhawi (Author), Hamide eAslan (Author), Jesus G Valenzuela (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The human immune response to saliva of Phlebotomus alexandri, the vector of visceral leishmaniasis in Iraq, and its relationship to sand fly exposure and infection.
by: Ines Lakhal-Naouar, et al.
Published: (2021) -
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.
by: Ana Paula Souza, et al.
Published: (2010) -
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
by: Pedro Cecílio, et al.
Published: (2017) -
The yin and yang of leishmaniasis control.
by: Shaden Kamhawi
Published: (2017) -
Review and A Brief Report on the Health Perspective, Causative Agents, Vectors, and Reservoirs of Visceral Leishmaniasis in Iran
by: Jalal Mohammadi, et al.
Published: (2022)